In addition, extensive capillary nonperfusion could induce neovascular glaucoma.[7,8] Over the past decades, the recommended treatments for RVO comprised laser photocoagulation, anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections and intravitreal steroid injections. This evidence concerns the gene VEGFA and neovascular glaucoma.